Is Everything a Challenge for Multiple Sclerosis patients? Nonverbal Semantic Memory Performance in Iranian Relapsing-Remitting Multiple Sclerosis Patients

被引:0
|
作者
Yazdani, Sara [1 ]
Sharifi, Shahla [1 ]
Foroughipour, Mohsen [2 ]
Gol, Atiyeh Kamyabi [1 ]
机构
[1] Ferdowsi Univ Mashhand, Linguist Dept, Mashhad, Razavi Khorasan, Iran
[2] Mashhad Univ Med Sci, Neurol Dept, Gaem Hosp, Mashhad, Razavi Khorasan, Iran
来源
BANGLADESH JOURNAL OF MEDICAL SCIENCE | 2021年 / 20卷 / 02期
关键词
nonverbal information; semantic memory; Multiple sclerosis; Iran; COGNITIVE IMPAIRMENT; INFORMATION; NEURODEGENERATION; DEMYELINATION; DEMENTIA; DEFICITS;
D O I
10.3329/bjms.v20i2.51554
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: The objective of the current study was to evaluate the nonverbal semantic memory performance of MS patients and compare it with their healthy counterparts. Materials and methods: In this study, 70 patients with definite relapsing-remitting multiple selerosis(15 men and 55 women) and 70 healthy individuals of comparable demographics (age, gender, and education) from patients' relatives and family members were selected based on convenient sampling. The patients recruited for this study were divided into two groups based on their Montreal Cognitive Assessment (MoCA) scores. The first group of patients (MS1) with MoCA scores of 18-25, and the MoCA scores of the second group (MS2) ranged from 10 -17. All of the participants were right-handed, originally born in Mashhad, Iran, and native speakers of Persian. To assess the nonverbal semantic memory performance of the participants, the picture version of The Camel and Cactus Test (CCT) was selected and administered from the Cambridge Semantic Memory battery test. Results: The results revealed that there was no significant difference between the MS1 and the Healthy Controls group in living and man-made variables, while MS2 performed significantly different compared to other groups in these variables. The results also showed that all three groups of participants performed significantly different from each other in reaction time variable. Conclusion: The findings showed that cognitive impairment in multiple sclerosis patients did not affect their nonverbal semantic memory performance, however, it had an impact on their reaction time.
引用
收藏
页码:390 / 395
页数:6
相关论文
共 50 条
  • [31] Pulsed methylprednisolone induces a reversible impairment of memory in patients with relapsing-remitting multiple sclerosis
    Oliveri, RL
    Sibilia, G
    Valentino, P
    Russo, C
    Romeo, N
    Quattrone, A
    ACTA NEUROLOGICA SCANDINAVICA, 1998, 97 (06): : 366 - 369
  • [32] Memory Impairment in Relapsing-Remitting Multiple Sclerosis Using a Challenging Semantic Interference Task
    Matias-Guiu, Jordi A.
    Cortes-Martinez, Ana
    Curiel, Rosie E.
    Delgado-Alvarez, Alfonso
    Fernandez-Oliveira, Anibal
    Pytel, Vanesa
    Montero, Paloma
    Moreno-Ramos, Teresa
    Loewenstein, David A.
    Matias-Guiu, Jorge
    FRONTIERS IN NEUROLOGY, 2020, 11
  • [33] Serum uric acid level in patients with relapsing-remitting multiple sclerosis
    Ashtari, Fereshteh
    Bahar, Mohammadali
    Aghaei, Maryam
    Zahed, Arash
    JOURNAL OF CLINICAL NEUROSCIENCE, 2013, 20 (05) : 676 - 678
  • [34] Intracortical excitability in patients with relapsing-remitting and secondary progressive multiple sclerosis
    Conte, A.
    Lenzi, D.
    Frasca, V.
    Gilio, F.
    Giacomelli, E.
    Gabriele, M.
    Bettolo, C. Marini
    Iacovelli, E.
    Pantano, P.
    Pozzilli, C.
    Inghilleri, M.
    JOURNAL OF NEUROLOGY, 2009, 256 (06) : 933 - 938
  • [35] Experience of Glatiramer Acetate in the Treatment of Relapsing-Remitting Multiple Sclerosis Patients
    Taskapilioglu, Ozlem
    Turan, Asli Bahar
    Albas, Murat
    Turan, Omer Faruk
    TURKISH JOURNAL OF NEUROLOGY, 2012, 18 (01) : 17 - 20
  • [36] Quality of life in 1000 patients with early relapsing-remitting multiple sclerosis
    Putzki, N.
    Fischer, J.
    Gottwald, K.
    Reifschneider, G.
    Ries, S.
    Siever, A.
    Hoffmann, F.
    Kaefferlein, W.
    Kausch, U.
    Liedtke, M.
    Kirchmeier, J.
    Gmuend, S.
    Richter, A.
    Schicklmaier, P.
    Niemczyk, G.
    Wernsdoerfer, C.
    Hartung, H. P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 (06) : 713 - 720
  • [37] Microstructural changes precede depression in patients with relapsing-remitting Multiple Sclerosis
    Riemer, Frank
    Skorve, Ellen
    Pasternak, Ofer
    Zaccagna, Fulvio
    Lundervold, Astri J.
    Torkildsen, Oivind
    Myhr, Kjell-Morten
    Gruner, Renate
    COMMUNICATIONS MEDICINE, 2023, 3 (01):
  • [38] Alemtuzumab improves contrast sensitivity in patients with relapsing-remitting multiple sclerosis
    Graves, Jennifer
    Galetta, Steven L.
    Palmer, Jeffrey
    Margolin, David H.
    Rizzo, Marco
    Bilbruck, John
    Balcer, Laura J.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (10) : 1302 - 1309
  • [39] Efficacy of fingolimod in patients with highly active relapsing-remitting multiple sclerosis
    Derfuss, T.
    Bergvall, N. K.
    Sfikas, N.
    Tomic, D. L.
    CURRENT MEDICAL RESEARCH AND OPINION, 2015, 31 (09) : 1687 - 1691
  • [40] No evidence for CCVSI in relapsing-remitting multiple sclerosis patients with moderate disability
    Martin Juenemann
    Mesut Yeniguen
    Erwin Stolz
    Martin Berghoff
    Journal of Neurology, 2013, 260 : 2409 - 2410